Civilization Ventures
Investment firm focused on genomics, synthetic biology, and computational biology. Backs companies at the intersection of biology and technology that can have transformative impact on human health and sustainability.
Location
San Francisco, USA
Founded
2017
AUM
$200M+
Investment Range
$1M - $15M
Focus
biotech-focused
Fund Stages
seed, series-a, series-b
Investment Thesis
Civilization Ventures focuses on companies leveraging advances in genomics, synthetic biology, and computational biology to create breakthrough solutions for human health and sustainability. They invest at the intersection of biology and engineering, backing founders building platform technologies with broad applications.
Team
Partners / Managing Directors (Health & Bio Focus)
- Omid Farokhzad, MD - Co-Founder & Partner
- Investment team with deep life sciences expertise
Other Key Team Members
- Scientific advisory network in genomics and synthetic biology
Focus Areas
- Genomics
- Synthetic Biology
- Computational Biology
- Gene Editing
- Cell Engineering
- Life Science Tools
- Healthcare Technology
Notable Exits
- Portfolio companies advancing through funding rounds
- Focus on early-stage company creation